The company's principal activity is to develop, market and license biopharmaceutical products for the human healthcare industry. The products are developed using liposomal drug delivery method that helps to deliver drugs to the intended target and release them with efficiency and control. Liposomes are microscopic cell-like spheres composed of a thin, durable lipid membrane surrounding a hollow compartment. The company develops three product lines namely, liprostin, nicotine receptor agonist and stent coating.
